GLC Europe is excited to welcome you to the Risk and Pharmacovigilance MasterClass on the 19 - 20 September 2019 in the historical city of Vienna, Austria. The MasterClass will be led by Dimitris Zampatis, Associate director, Signal and Risk Management Process at Merck Biopharma, Germany.
The focus of this two-day masterclass will be on providing an update of ongoing medicines risk and signal management. Participants will also have the opportunity to get an insight on the current signal detection and management guidelines and tools. During this training, an outlook of current and future challenges in pharmacovigilance focusing on the impact of the General Data Protection Regulation (GDPR) in May 2018 will be given and discussed.
By the end of this MasterClass, participants will:
Learn all the details about the RMP Structure and compilation
Discover the risk minimization measures
Have a closer look on the signal detection and the MAH experience in EVDAS
Get to know the EU guidelines and the authorities’ expectation on signal management
For the training description, detailed trainer profile and training program, please request the Training Agenda!